HIV diagnostic testing has come a long way since its inception in the early s. Current enzyme immunoassays are sensitive enough to detect antibody as early as one to two weeks after infection. A variety of other assays are essential to confirm positive antibody screens Western blot, polymerase chain reaction [PCR] , provide an adjunct to antibody testing p24 antigen, PCR , or provide additional information for the clinician treating HIV-positive patients qualitative and quantitative PCR, and genotyping. Point of Care tests have become increasingly popular in the United States and some places in Canada over the past several years. HIV infection is identified either by the detection of HIV-specific antibodies in serum or plasma or by demonstrating the presence of the virus by nucleic acid detection using polymerase chain reaction PCR , p24 antigen testing or, rarely these days, by growing virus in cell culture.
They were able to detect infection approximately 1 week earlier than the first-generation assays [ 15 ]. Routine daily, weekly and monthly equipment maintenance must be carried out as per the manufacturer's instructions. Several studies published recently have supported the proposed algorithm. Antibodies to HIV can be measured by a variety of techniques. Submit Cancel. University of California San Francisco. The requesting physician should ensure that all tests are done in a quality laboratory. Diagnosric from diagnostic HIV testing, laboratories may also offer quantitative PCR RNA testing viral loadwhich Methods to diagnostic hiv used to help determine the initiation of drug therapy and Methods to diagnostic hiv the effectiveness of therapy. The counsellor should also be prepared to deliver key and concise messages when the test is done in an urgent setting, such as while in labour.
Andrew fetus hare. 5.1. Laboratory quality assurance
Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Accessed 5 October The basic recommendations are as follows:. Abstract HIV diagnostic testing has come a long way since its inception in the early s. A diagnstic Methods to diagnostic hiv antibodyantigen and nucleic acid tests are used by blood banks in Western countries. Cultures for HSV usually become positive within 1—3 days. These assays are used because they are highly sensitive and generally amenable to automation, facilitating Methods to diagnostic hiv testing. The major performance and operational characteristics of commercially available serological assays are summarized in WHO reports available on the web site of the department of Methods to diagnostic hiv Health Giv Nick is proud to be able to help eliminate the stigma of STD testing through his writing and is always trying to advocate the importance of your sexual health. Testing for acute HIV infection: implications for treatment as prevention. Acute HIV infection has been defined as both a transient nonspecific Throat constricts syndrome associated with high viral replication and as the diagnoatic between appearance of detectable p24 or HIV Hvi and detectable antibodies Methods to diagnostic hiv 6 ]. Fourth-generation assays became available in the United States inalthough similar combination assays have been utilized in other countries since a decade earlier. Gastrointestinal tract infection. Aside from diagnostic HIV testing, laboratories may also offer quantitative PCR RNA testing viral loadwhich is diagnoatic to help determine the initiation of drug therapy and monitor the effectiveness of therapy. Please check for further notifications by email.
Julia Kang Cornett, Thomas J.
- HIV diagnostic testing has come a long way since its inception in the early s.
- Each HIV test has its own testing window and each test detects HIV by looking for different specimens in a blood sample.
HIV diagnostic testing has come a long way since its inception in the early s. Current enzyme immunoassays are sensitive enough to detect antibody as early as one to two weeks after infection.
A variety of other assays are essential to confirm positive antibody screens Western blot, polymerase chain reaction [PCR] , provide an adjunct to antibody testing p24 antigen, PCR , or provide additional information for the clinician treating HIV-positive patients qualitative and quantitative PCR, and genotyping.
Point of Care tests have become increasingly popular in the United States and some places in Canada over the past several years. HIV infection is identified either by the detection of HIV-specific antibodies in serum or plasma or by demonstrating the presence of the virus by nucleic acid detection using polymerase chain reaction PCR , p24 antigen testing or, rarely these days, by growing virus in cell culture.
In a small number of early seroconverters who are still in the 'window period', the p24 antigen may become positive before antibody is detectable. Therefore, to enable the laboratory to select appropriate testing, it is important to provide a clinical history that includes any recent high-risk behaviour or symptoms consistent with seroconversion illness 1 - 3.
Some laboratories may use a radioimmunoprecipitation assay as their confirmatory assay or as part of their HIV testing algorithm. In a radioimmunoprecipitation assay test, radiolabelled viral proteins are reacted with the patient's serum to produce radioactive antigen-antibody complexes.
PCR is particularly useful in testing infants of HIV-positive mothers; these infants may carry maternal antibody to 15 months of age 4. It is also useful when testing patients who are agammaglobulinemic or in rare cases where patients appear to have symptoms of advanced HIV infection but do not demonstrate HIV-specific antibodies.
Aside from diagnostic HIV testing, laboratories may also offer quantitative PCR RNA testing viral load , which is used to help determine the initiation of drug therapy and monitor the effectiveness of therapy. HIV genotyping is a newer adjunct to patient management and is used to assist in tracking the development of drug resistance and guide the modification of antiretroviral drug selection 3.
Strongly positive screen test samples, which give an indeterminate or unusual HIV-1 Western blot pattern, are retested on a specific HIV-2 blot. If possible, a dedicated tube for HIV testing is preferred to minimize the possibility of cross contamination during handling.
Laboratories should provide their clients with specific guidelines on the collection and submission of samples for HIV testing locally. Performance of these assays, including p24 antigen testing, has been validated on serum and plasma.
The assays have not been validated on post-mortem specimens or body fluids such as urine, saliva, semen or pleural fluid. A number of tests designed specifically for urine, oral fluid or finger-prick specimens are in use for testing in special circumstances eg, insurance screening, population surveillance. Specimens are collected as indicated by the manufacturer. Any sample that has been previously frozen should be indicated as such because special handling may be required for some of the test kits currently in use.
For shipping to the laboratory, specimens must be packaged and labelled in compliance with Transport Canada's Transportation of Dangerous Goods regulations 6 as they apply to the shipment of clinical specimens. All clinical diagnostic specimens must be properly labelled with a patient identifier and accompanied by a completed laboratory requisition with relevant clinical information to guide appropriate test selection.
Laboratories must provide clients with guidelines for the collection, storage, shipping, timing and types of tubes used for PCR testing. These specimens generally need to be processed within 48 h of collection. Blood collection tubes may vary depending on the PCR assay being used.
Do not freeze! Processing to prepare the specimen for testing must take place within 48 h of collection. Viral DNA denatures over time and becomes undetectable. Whole blood in EDTA is stable for only 4 h, while blood in PPT, if centrifuged within 4 h of collection, is stable at room temperature for 24 h. Plasma can be stored frozen for three months before testing, and is stable for 24 h at room temperature.
Only Health Canada-approved tests should be used by diagnostic laboratories in Canada. These assays are used because they are highly sensitive and generally amenable to automation, facilitating high-volume testing. Laboratories may choose to first test with a second EIA assay, which uses a different part of the viral antigen for antibody capture, as part of their testing algorithm. Specimens that screen positive in the first assay but negative in the second assay should still be considered for confirmatory testing if the patient is symptomatic or high risk.
In rare instances, the p24 antigen can be detected before HIV antibody in newly infected individuals. A follow-up HIV antibody test should be requested when a patient is p24 antigen-positive but antibody-negative.
In a seroconverting patient, the follow-up specimen will be positive within a few weeks after the initial screen. It is important to remember that not all seroconverting patients will have detectable p24 antigen, and that this antigen may not be reliably found in individuals who are known to be HIV antibody-positive.
The Western blot is an immunoblot that allows for the characterization of antibodies to each viral protein. Patient serum is reacted with a nitrocellulose strip containing all of the constitutive HIV virus proteins core and envelope , arranged by molecular weight after polyacrylamide gel electrophoresis. Any specific antibodies present in the patient's serum will bind to the antigen, producing a coloured band when alkaline phosphatase-labelled, antihuman immunoglobulin G conjugate and colour development solution are added.
These bands can be visualized, and positivity is assessed following the manufacturer's recommendations and based on the number and type of bands present. Generally, a specimen must show a positive reaction with a minimum of one core band and one envelope band to be judged positive by Western blot. Specimens that have bands present but do not fulfill the criteria for positivity are called Western blot indeterminate, and a follow-up specimen should be requested, usually collected three to four weeks after the initial specimen.
In follow-up, patients will either show a definitive pattern indicating that they have seroconverted or will demonstrate the same banding pattern as previously observed.
In the latter circumstance, the vast majority of these patients are HIV-negative and have nonspecific antibody. Because these indeterminate banding patterns may be seen in patients who are not infected, the Western blot does not make a good screening test for HIV.
PCR is a method that amplifies viral nucleic acid to allow for its detection in patient specimens. It is a particularly specific and sensitive test which can pick up very small numbers of viral particles. Babies will carry maternal antibody up to approximately 15 months of age and, therefore, the antibody test is not a reliable indicator of infection in these children. In North America, this would be a very uncommon finding. It is used in conjunction with CD4 counts and general clinical assessments to ascertain when therapy should be started.
It is also used to help determine the patient's response to therapy. Genotyping is used to monitor the development or presence of drug resistance in patients before or during therapy. It is also used to assist physicians in their choice of antiretroviral drug combinations for the patient 3 , 7. Quantitative PCR should not be used as a diagnostic test for HIV because false positives and false negatives can occur in these circumstances.
POC testing is testing carried out wherever the patient is located - in a clinic, hospital or doctor's office. The use of such testing varies across Canada, with some provinces not using it at all and others using it extensively in sexually transmitted infection clinics or hospitals and as a preliminary screen for needlestick exposures in a health care setting 8. The basic recommendations are as follows:. These tests should be used only in sites that provide a comprehensive quality assurance program as it relates to laboratory testing, as stated below.
Participation in proficiency testing is a key component of any laboratory quality assurance program, whether available locally, nationally or internationally When external proficiency programs are not available, groups of laboratories may set up their own proficiency testing program by sharing samples among themselves. At the time of writing, the aforementioned proficiency testing programs are available free of charge to participants the only costs are reagents and staff time.
QMP-LS charges out-of-province participants. This ensures that physicians receive accurate and timely laboratory information to guide patient management. Regular audits of laboratory procedures and reviews of incident reports should be carried out by senior staff and summarized for discussion with the laboratory director 10 , An up-to-date, complete laboratory manual or manual of standard operating procedures is an important component of the quality assurance program.
The manual should be reviewed regularly by senior staff and the laboratory director, and all staff must read and be familiar with the procedures they are responsible for performing in the laboratory. Reagent and equipment performance must be monitored over time to detect any changes in quality and integrity.
Routine daily, weekly and monthly equipment maintenance must be carried out as per the manufacturer's instructions. Levy-Jennings plots should be performed on a regular basis and reviewed by a senior technologist for any aberrant values or shifts in control performance.
Controls should be selected to include weak positives or borderline samples as well as those giving a strong positive and negative result on each assay used in the laboratory. On automated instruments, controls should be placed in a position to detect carry-over. Procedures to be followed when controls are out of range must be clearly described in the laboratory manual, and problems and corrective action should be documented by laboratory staff. National Center for Biotechnology Information , U.
Author information Copyright and License information Disclaimer. All rights reserved. This article has been cited by other articles in PMC.
Abstract HIV diagnostic testing has come a long way since its inception in the early s. Open in a separate window. Figure 1. Diagnostic Tests Only Health Canada-approved tests should be used by diagnostic laboratories in Canada.
Western blot The Western blot is an immunoblot that allows for the characterization of antibodies to each viral protein. POC: POC testing is testing carried out wherever the patient is located - in a clinic, hospital or doctor's office. The basic recommendations are as follows: Only a Health Canada-approved device should be used.
Proficiency And Quality Assurance Proficiency testing Participation in proficiency testing is a key component of any laboratory quality assurance program, whether available locally, nationally or internationally References 1. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral.
Zhang M, Versalovic J. HIV update. Diagnostic tests and markers of disease progression and response to therapy. Canadian STD Guidelines , edn. Ottawa: Health Canada, Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: A Brazilian study.
J Clin Microbiol ; 40 Transportation of Dangerous Goods Act, Clin Infect Dis ; 37
With the increasing use of antiviral drugs, antiviral drug resistance has become a clinical problem. Quantitative PCR should not be used as a diagnostic test for HIV because false positives and false negatives can occur in these circumstances. Virus-specific IgG antibody assays are used to determine past infection and specific immune status. When external proficiency programs are not available, groups of laboratories may set up their own proficiency testing program by sharing samples among themselves. Advance article alerts.
Methods to diagnostic hiv. WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children.
These tests look for antibodies to the virus that the body creates in an attempt to fight the virus. People exposed to the virus should get tested immediately, although it can take the body anywhere from six weeks to a year to develop antibodies to the virus.
Follow-up tests may be needed depending on the initial time of exposure. Early testing is crucial. If you test positive for the virus, you and your doctor will discuss and develop a treatment plan that can help fight HIV and ward off complications.
Early testing also can alert you to avoid high-risk behavior that can spread the virus to others. Anonymous and free testing also is available. During testing, your doctor will ask about your symptoms, medical history and risk factors, and perform a physical examination. Need a doctor? Call us at UCSF or browse our directory. University of California San Francisco. MyChart Find a Doctor.